Most Recent
Teva wins docs to bolster case that Boehringer’s Spiriva patents were obvious
Israeli drug maker Teva has won its bid for communications between Germany-based Boehringer and capsule manufacturers to help prove its claim that a patent at the centre of a dispute over the top-selling inhaler Spiriva was invalid for obviousness.
Deloitte grilled after claiming partners have no right to access files from litigation room
Lawyers for Deloitte were questioned by an appeals court Monday after arguing that the accounting giant's partners had no access to the firm's files, stored in a locked "litigation room", and no power to hand them over to comply with discovery orders in a shareholder class action over the collapse of client Hastie Group.
Maurice Blackburn says it can deliver the goods in BHP class action
Law firm Maurice Blackburn has fired its opening salvo in a high-stakes appeal of a judge's decision rejecting its class action against BHP over the Brazilian dam failure, saying the ruling deprived group members of pocketing higher net returns on any recovery and of choosing a more experienced firm to run the case for them.
Education Department got bad advice from Clayton Utz, court told
Clayton Utz's advice to the Department of Education that it could supply details to the ACCC about documents seized in an Australian Federal Police raid of Phoenix Institute of Australia's offices was incorrect, the collapsed educational company told the court as it flagged a possible application to shut down the consumer watchdog's case.
Judge calls for criteria to pick winner in competing class action battles
The courts should be given express statutory power to resolve competing class actions that establishes the factors to consider when picking a winning case, a leading class action judge has said.
‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court
The Full Court has denied a request by Sanofi that it review a judge's refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant's appeal "misconceived".
REA, Domain settle trade mark lawsuit over realestate.com redirect
Property listing rivals REA Group and Domain have settled a trade mark lawsuit over an agreement between Domain and the owner of US website realestate.com to redirect Australian traffic to Domain's website.
Sanofi slams judge’s harm assessment in denying injector pen injunction
A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.
Deloitte continues fight to keep Hastie files secret after claiming partner made off with them
Deloitte is challenging a judge's ruling that certain partners not be excused from an order to produce files of the accounting giant's audit work for Hastie Group to shareholders in a class action over the construction company's collapse, its latest move after a failed attempt to persuade the judge that a rogue partner had taken the only copies of the files and refused to give them back.
Boutique firm Phi Finney McDonald ’eminently qualified’ to run BHP class action, experts say
Class action experts have come to the defence of boutique law firm Phi Finney McDonald as heavyweight Maurice Blackburn appeals a judge's ruling to choose the "less experienced" firm to lead a shareholder class action against BHP Billiton.